DOX logo

Amdocs Limited (DOX) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$346.08 M
-$174.00 M-33.46%

September 30, 2024


Summary


Performance

DOX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDOXbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$213.83 M
-$132.25 M-38.21%

December 31, 2024


Summary


Performance

DOX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDOXbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

DOX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.5%-37.6%
3 y3 years-51.2%-63.9%
5 y5 years-26.6%-78.3%

DOX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-51.2%at low-65.7%at low
5 y5-year-64.8%at low-84.0%at low
alltimeall time-68.6%+1262.5%-84.0%+1081.4%

Amdocs Limited Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$213.83 M(-38.2%)
Sep 2024
$346.08 M(-33.5%)
$346.08 M(+8.8%)
Jun 2024
-
$317.99 M(-7.3%)
Mar 2024
-
$342.92 M(-10.4%)
Dec 2023
-
$382.88 M(-26.4%)
Sep 2023
$520.08 M(-9.3%)
$520.08 M(+0.5%)
Jun 2023
-
$517.66 M(-17.0%)
Mar 2023
-
$623.40 M(+26.7%)
Dec 2022
-
$492.18 M(-14.2%)
Sep 2022
$573.38 M(-19.1%)
$573.38 M(-4.1%)
Jun 2022
-
$597.76 M(+0.8%)
Mar 2022
-
$593.06 M(+1.1%)
Dec 2021
-
$586.49 M(-17.3%)
Sep 2021
$709.06 M(-27.9%)
$709.06 M(-16.9%)
Jun 2021
-
$853.30 M(-11.9%)
Mar 2021
-
$968.99 M(-27.5%)
Dec 2020
-
$1.34 B(+35.9%)
Sep 2020
$983.19 M(+108.5%)
$983.19 M(-17.7%)
Jun 2020
-
$1.19 B(+56.6%)
Mar 2020
-
$762.60 M(+57.0%)
Dec 2019
-
$485.88 M(+3.0%)
Sep 2019
$471.63 M(+12.6%)
$471.63 M(+15.7%)
Jun 2019
-
$407.79 M(+2.2%)
Mar 2019
-
$399.19 M(+11.3%)
Dec 2018
-
$358.66 M(-14.4%)
Sep 2018
$418.78 M(-35.5%)
$418.78 M(-9.1%)
Jun 2018
-
$460.56 M(-2.2%)
Mar 2018
-
$470.93 M(-26.5%)
Dec 2017
-
$640.78 M(-1.4%)
Sep 2017
$649.61 M(-15.5%)
$649.61 M(+2.1%)
Jun 2017
-
$636.53 M(-22.6%)
Mar 2017
-
$822.73 M(+34.0%)
Dec 2016
-
$613.82 M(-20.1%)
Sep 2016
$768.66 M(-25.8%)
$768.66 M(-4.1%)
Jun 2016
-
$801.19 M(-2.7%)
Mar 2016
-
$823.46 M(-4.9%)
Dec 2015
-
$865.89 M(-16.4%)
Sep 2015
$1.04 B(-6.1%)
$1.04 B(-3.8%)
Jun 2015
-
$1.08 B(+10.7%)
Mar 2015
-
$972.63 M(+2.2%)
Dec 2014
-
$951.44 M(-13.8%)
Sep 2014
$1.10 B(+8.8%)
$1.10 B(+29.2%)
Jun 2014
-
$853.94 M(+8.6%)
Mar 2014
-
$786.04 M(-11.7%)
Dec 2013
-
$890.58 M(-12.2%)
Sep 2013
$1.01 B(+15.4%)
$1.01 B(+28.9%)
Jun 2013
-
$786.78 M(+18.9%)
Mar 2013
-
$661.79 M(+3.3%)
Dec 2012
-
$640.77 M(-27.1%)
Sep 2012
$879.16 M(+5.7%)
$879.16 M(+50.6%)
Jun 2012
-
$583.77 M(+2.0%)
Mar 2012
-
$572.26 M(-4.1%)
Dec 2011
-
$596.42 M(-28.3%)
DateAnnualQuarterly
Sep 2011
$831.37 M(-19.8%)
$831.37 M(+3.3%)
Jun 2011
-
$805.17 M(-0.9%)
Mar 2011
-
$812.61 M(-8.9%)
Dec 2010
-
$891.86 M(-13.9%)
Sep 2010
$1.04 B(+42.2%)
$1.04 B(+54.4%)
Jun 2010
-
$671.15 M(-13.6%)
Dec 2009
-
$776.78 M(+6.6%)
Sep 2009
$728.76 M(+1.4%)
$728.76 M(-4.4%)
Mar 2009
-
$762.35 M(-40.4%)
Dec 2008
-
$1.28 B(+78.0%)
Sep 2008
$718.85 M(+16.8%)
$718.85 M(+4.6%)
Jun 2008
-
$687.23 M(+1.0%)
Mar 2008
-
$680.67 M(-41.7%)
Dec 2007
-
$1.17 B(+89.6%)
Sep 2007
$615.50 M(+1.4%)
$615.50 M(-1.3%)
Jun 2007
-
$623.64 M(+0.4%)
Mar 2007
-
$621.23 M(+9.9%)
Dec 2006
-
$565.29 M(-6.9%)
Sep 2006
$607.19 M(-14.2%)
$607.19 M(+25.1%)
Jun 2006
-
$485.46 M(-10.9%)
Mar 2006
-
$545.02 M(+2.0%)
Dec 2005
-
$534.39 M(-24.5%)
Sep 2005
$707.55 M(+28.6%)
$707.55 M(+10.7%)
Jun 2005
-
$639.42 M(+17.0%)
Mar 2005
-
$546.70 M(-7.4%)
Dec 2004
-
$590.59 M(+7.3%)
Sep 2004
$550.35 M(-35.1%)
$550.35 M(+11.8%)
Jun 2004
-
$492.45 M(-38.2%)
Mar 2004
-
$796.32 M(+44.2%)
Dec 2003
-
$552.21 M(-34.8%)
Sep 2003
$847.60 M(+81.6%)
$847.60 M(+27.5%)
Jun 2003
-
$664.65 M(+3.5%)
Mar 2003
-
$642.06 M(+12.2%)
Dec 2002
-
$572.27 M(+22.6%)
Sep 2002
$466.65 M(-46.5%)
$466.65 M(+10.2%)
Jun 2002
-
$423.42 M(-12.0%)
Mar 2002
-
$480.98 M(+6.2%)
Dec 2001
-
$452.86 M(-48.1%)
Sep 2001
$873.00 M(+117.0%)
$873.00 M(+5.3%)
Jun 2001
-
$829.41 M(+138.5%)
Mar 2001
-
$347.83 M(-2.2%)
Dec 2000
-
$355.53 M(-11.6%)
Sep 2000
$402.30 M(+372.2%)
$402.30 M(+32.8%)
Jun 2000
-
$302.97 M(+36.5%)
Mar 2000
-
$221.94 M(+33.9%)
Dec 1999
-
$165.80 M(+94.6%)
Sep 1999
$85.20 M(+235.4%)
$85.20 M(+19.8%)
Jun 1999
-
$71.10 M(+164.3%)
Mar 1999
-
$26.90 M(+48.6%)
Dec 1998
-
$18.10 M(-28.7%)
Sep 1998
$25.40 M(-52.7%)
$25.40 M(-39.1%)
Jun 1998
-
$41.70 M
Sep 1997
$53.70 M
-

FAQ

  • What is Amdocs Limited annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Amdocs Limited?
  • What is Amdocs Limited annual cash & cash equivalents year-on-year change?
  • What is Amdocs Limited quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Amdocs Limited?
  • What is Amdocs Limited quarterly cash and cash equivalents year-on-year change?

What is Amdocs Limited annual cash & cash equivalents?

The current annual cash & cash equivalents of DOX is $346.08 M

What is the all time high annual cash & cash equivalents for Amdocs Limited?

Amdocs Limited all-time high annual cash & cash equivalents is $1.10 B

What is Amdocs Limited annual cash & cash equivalents year-on-year change?

Over the past year, DOX annual cash & cash equivalents has changed by -$174.00 M (-33.46%)

What is Amdocs Limited quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of DOX is $213.83 M

What is the all time high quarterly cash and cash equivalents for Amdocs Limited?

Amdocs Limited all-time high quarterly cash and cash equivalents is $1.34 B

What is Amdocs Limited quarterly cash and cash equivalents year-on-year change?

Over the past year, DOX quarterly cash and cash equivalents has changed by -$129.08 M (-37.64%)